1st large prospective study looking at PRO before / after breast cancer. n=4 000, 1st set of CANTO (n=12 000). Key msg; Endocrine therapy dramatically alters PRO (more than chemo in post-meno pts); there is an urgent need to de-escalate ET : biomarkers !